| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
| 04/27/2011 | EP2313423A2 Nucleic acid comprising zwitterionic nucleotides |
| 04/27/2011 | EP2313374A1 6-substituted isoquinolines and isoquinolinones |
| 04/27/2011 | EP2313116A1 Improved bacterial polysaccharide-polypeptide conjugate compositions |
| 04/27/2011 | EP2313107A1 Catabolic agents |
| 04/27/2011 | EP2039367B1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 04/27/2011 | EP1793671B1 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity |
| 04/27/2011 | EP1670444B1 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1439175B1 Pyrimidine compound and medicinal composition thereof |
| 04/27/2011 | EP1383463B1 Fused thiophene compounds and use thereof in the treatment of chronic pain |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP1197218B1 Algae protein polysaccharide extraction and use thereof |
| 04/27/2011 | EP1118660B1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/27/2011 | EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 04/27/2011 | CN201806957U Moxa bathing bag |
| 04/27/2011 | CN1861114B Application of Qishen Yiqi dripping pills for preparing medicine for preventing and treating high-altitude oxygen deficit |
| 04/27/2011 | CN1556706B Thieno [1,3] oxazin-4-ones with lipase inhibiting activity |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102036972A Treatment of duchenne muscular dystrophy |
| 04/27/2011 | CN102036962A Combined use of angiogenesis inhibitor and taxane |
| 04/27/2011 | CN102036740A Filtration method |
| 04/27/2011 | CN102036664A Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 04/27/2011 | CN102036659A Modulators of the prostacyclin (PGi2) receptor useful for the treatment of disorders related thereto |
| 04/27/2011 | CN102030818A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030817A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030771A Compound used as transient receptor potential vanilloid (TRPV1) blocker, medicinal composition and pharmaceutical application thereof |
| 04/27/2011 | CN102030749A Novel process and formulations |
| 04/27/2011 | CN102028929A Raw dried ginger buccal tablet administrated with medicine |
| 04/27/2011 | CN102028878A Yin-nourishing heat-clearing pills and preparation method thereof |
| 04/27/2011 | CN102028862A Anti-heat stress Chinese herbal additive for domestic animals |
| 04/27/2011 | CN102028853A Traditional Chinese medicine for preventing and controlling caverned disease of Japanese koi |
| 04/27/2011 | CN102028820A Externally-applied medicament for radical treatment of all types of cancers and difficult and complicated diseases |
| 04/27/2011 | CN102028802A Blood-activating traditional Chinese medicine formula used in pillow inner |
| 04/27/2011 | CN102028719A Prescription mainly used for treating gynecological extreme tickle, superbug, severe anhydremia and intractable diseases |
| 04/27/2011 | CN101642533B Traditional Chinese medicine preparation capable of enhancing SOD activity and lowering MDA content |
| 04/27/2011 | CN101590058B Medicinal composition containing dihydroergocryptine A mesylate |
| 04/27/2011 | CN101219985B N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 04/27/2011 | CN101143192B Therapeutic gastrodia extracts |
| 04/27/2011 | CN101068533B Pharmaceutical composition containing an anti-nucleating agent |
| 04/27/2011 | CN101019645B Health food for remitting fatigue and raising hypoxia tolerance and its preparation method |
| 04/27/2011 | CN101006846B Anti-stress nutrition additives for poultry and its preparation method |
| 04/26/2011 | US7932371 Tick octopamine receptor nucleic acid molecules |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932281 Amine-based compound and use thereof |
| 04/26/2011 | US7932271 Heterocyclic methyl sulfone derivative |
| 04/26/2011 | US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group |
| 04/26/2011 | US7931902 Using transgenic animal models as tools in identifying and treating cell proliferative, cardiovascular, vision, muscular, nervous system, bone and metabolic disorders |
| 04/26/2011 | CA2543676C Tyrosinase activity inhibitor and ameliorant for facial blood flow |
| 04/26/2011 | CA2496611C Agent delivery particle |
| 04/26/2011 | CA2491506C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2462657C Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 04/26/2011 | CA2462416C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2430707C 8-{4-[3-(5-fluoro-1h-indol-3-yl)propyl]-piperazin-1-yl}-2-methyl-4h-benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine d2 receptor and the serotonin reuptake site |
| 04/26/2011 | CA2424565C Novel crystalline forms of a factor xa inhibitor |
| 04/26/2011 | CA2408838C Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2371109C Improved pharmaceutical formulations |
| 04/26/2011 | CA2359945C Inhibitors of crystallization in a solid dispersion |
| 04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011046200A1 Antiinflammatory agent comprising differentiation-inducing factor or analog thereof |
| 04/21/2011 | WO2011046057A1 Novel sugar chain compound containing sialyllactosamine-type or sialyl lewis x-type sialic acid and fucose |
| 04/21/2011 | WO2011045341A1 Ido inhibitors and therapeutic uses thereof |
| 04/21/2011 | WO2011019134A3 Vaccine composition including salmonella microorganism variants for preventing fowl typhoid |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092593 Water-Soluble Colonoscopy Lubricant |
| 04/21/2011 | US20110092533 Compounds for binding to er alpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 04/21/2011 | US20110092481 Quinoline or isoquinoline substituted p2x7 antagonists |
| 04/21/2011 | US20110092471 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 04/21/2011 | US20110092450 Method of enhancing the mobilization of hematopoietic stem cells using tat-hoxb4h |
| 04/21/2011 | US20110092449 Treatment of fibrotic conditions |
| 04/21/2011 | US20110092443 Cyclosporine compositions for enhancing nail growth |
| 04/21/2011 | US20110092437 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091578 Method of stimulating tissue healing |
| 04/21/2011 | US20110091548 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 04/21/2011 | US20110091545 Direct Injection moldable and rapidly disintegrating tablet matrix |
| 04/21/2011 | US20110091521 Edible spoon for dissociating into consumable predetermined clumps in order to prevent dissociating into random granules that would make consumption more difficult |
| 04/21/2011 | US20110091519 Controlling resorption of bioresorbable medical implant material |
| 04/21/2011 | US20110091510 Nanorod materials and methods of making and using same |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091432 Isolated pediococcus acidilactici 05b0111 and method of producing exopolysaccharide |
| 04/21/2011 | US20110091429 Methods for Enhancing Stem Cell Engraftment During Transplantation |
| 04/21/2011 | US20110091426 Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cells |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311938A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |